Nissay Asset Management Corp Japan Acquires 46,952 Shares of Astera Labs, Inc. $ALAB

Nissay Asset Management Corp Japan increased its position in shares of Astera Labs, Inc. (NASDAQ:ALABFree Report) by 79.6% in the second quarter, HoldingsChannel reports. The firm owned 105,965 shares of the company’s stock after purchasing an additional 46,952 shares during the period. Nissay Asset Management Corp Japan’s holdings in Astera Labs were worth $51,183,000 at the end of the most recent reporting period.

Other institutional investors and hedge funds also recently made changes to their positions in the company. Keating Financial Advisory Services Inc. acquired a new position in Astera Labs during the second quarter worth $25,000. Archer Investment Corp purchased a new stake in Astera Labs during the 2nd quarter valued at $30,000. Transamerica Financial Advisors LLC purchased a new stake in Astera Labs in the 2nd quarter worth $35,000. Johnson Financial Group Inc. bought a new position in Astera Labs during the second quarter valued at $43,000. Finally, Bell Investment Advisors Inc purchased a new position in Astera Labs during the 2nd quarter valued at about $43,000. Institutional investors and hedge funds own 60.47% of the company’s stock.

Analysts Set New Price Targets

ALAB has been the topic of a number of research reports. Weiss Ratings reissued a “hold (c)” rating on shares of Astera Labs in a research note on Tuesday, August 18th. Evercore reiterated an “outperform” rating and issued a $297.00 price target on shares of Astera Labs in a research note on Tuesday, May 19th. Royal Bank Of Canada raised their price objective on Astera Labs from $425.00 to $500.00 and gave the company an “outperform” rating in a report on Wednesday, August 5th. Zacks Research upgraded Astera Labs from a “hold” rating to a “strong-buy” rating in a report on Tuesday, August 11th. Finally, Roth Capital reiterated a “buy” rating and issued a $450.00 target price on shares of Astera Labs in a report on Wednesday, August 5th. One analyst has rated the stock with a Strong Buy rating, thirteen have assigned a Buy rating and eight have assigned a Hold rating to the company’s stock. According to data from MarketBeat, the stock presently has a consensus rating of “Moderate Buy” and an average price target of $340.53.

View Our Latest Research Report on Astera Labs

Insider Activity

In other Astera Labs news, Director Stefan A. Dyckerhoff sold 8,994 shares of the firm’s stock in a transaction on Thursday, August 6th. The stock was sold at an average price of $311.83, for a total transaction of $2,804,599.02. Following the completion of the transaction, the director owned 3,970 shares of the company’s stock, valued at approximately $1,237,965.10. This trade represents a 69.38% decrease in their ownership of the stock. The sale was disclosed in a filing with the SEC, which can be accessed through this link. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. Also, General Counsel Philip Mazzara sold 6,801 shares of the stock in a transaction that occurred on Monday, August 17th. The shares were sold at an average price of $340.50, for a total transaction of $2,315,740.50. Following the sale, the general counsel directly owned 96,542 shares of the company’s stock, valued at approximately $32,872,551. This trade represents a 6.58% decrease in their ownership of the stock. Additional details regarding this sale are available in the official SEC disclosure. The sale was made to cover tax withholding obligations related to the vesting of equity awards. Over the last three months, insiders sold 419,244 shares of company stock valued at $163,135,169. Company insiders own 10.40% of the company’s stock.

Astera Labs Trading Down 4.8%

Astera Labs stock opened at $289.47 on Friday. Astera Labs, Inc. has a 12-month low of $97.89 and a 12-month high of $499.48. The company has a 50-day moving average price of $342.38 and a 200 day moving average price of $249.65. The stock has a market cap of $50.22 billion, a P/E ratio of 143.30 and a beta of 3.84.

Astera Labs (NASDAQ:ALABGet Free Report) last issued its earnings results on Tuesday, August 4th. The company reported $0.80 earnings per share for the quarter, beating analysts’ consensus estimates of $0.69 by $0.11. Astera Labs had a return on equity of 19.24% and a net margin of 30.74%.The firm had revenue of $392.40 million for the quarter, compared to analysts’ expectations of $360.85 million. During the same quarter last year, the firm earned $0.44 earnings per share. The firm’s revenue for the quarter was up 104.5% compared to the same quarter last year. Astera Labs has set its Q3 2026 guidance at 1.160-1.210 EPS. As a group, analysts forecast that Astera Labs, Inc. will post 2.7 EPS for the current year.

Astera Labs Company Profile

(Free Report)

Astera Labs is a fabless semiconductor company that develops connectivity solutions for data center and cloud infrastructure. The firm focuses on addressing signal integrity and link management challenges that arise as server architectures incorporate higher-bandwidth processors and accelerators. Its technology is aimed at improving reliability and performance for high-speed interconnects used in servers, storage systems and compute accelerators.

The company’s product portfolio centers on silicon devices and accompanying firmware and software that enhance and manage high-speed links.

Featured Articles

Want to see what other hedge funds are holding ALAB? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Astera Labs, Inc. (NASDAQ:ALABFree Report).

Institutional Ownership by Quarter for Astera Labs (NASDAQ:ALAB)

Receive News & Ratings for Astera Labs Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Astera Labs and related companies with MarketBeat.com's FREE daily email newsletter.